小胶质细胞激活介导非特异性炎症在血管性认知障碍白质脱髓鞘损伤机制中的研究进展

摘要/Abstract

摘要： 小胶质细胞作为中枢神经系统免疫监视的主要细胞，在脑组织急慢性缺血性损伤中可通过介导炎症及氧化应激反应释放多种具有神经毒性的产物，进一步引起神经元和其他胶质细胞的死亡。血管性认知障碍作为脑组织慢性缺血性损伤导致的一种以磁共振成像下脑白质脱髓鞘为特征的疾病，缺血性非特异炎症在其白质损伤中的作用机制愈发得到重视。本文对有关脑组织缺血引起小胶质细胞激活所介导非特异性炎症进而造成脑白质脱髓鞘损伤的机制相关研究做一综述，以期能够为进一步的相关机制研究提供参考和帮助。

文章导读： 小胶质细胞在脑缺血损伤后的极化（M1型与M2型）对脑白质髓鞘损伤及修复具有不同作用和机制。本文对小胶质细胞与血管性认知障碍白质损伤的关系进行了综述，为进一步寻找血管性认知障碍的治疗靶点提供参考。

关键词: 小胶质细胞; 炎症; 血管性认知障碍; 脑白质损伤; 少突胶质细胞

Abstract: Microglia as the main immune surveillance cell in central nervous system can cause acute or chronic cerebral ischemic injury via mediating inflammation and oxidative stress and releasing varieties of products with neurotoxicity, which could even cause the death of neurons and other glial cells. White matter demyelinatingis the feature of vascular cognitive impairment, marked by magnetic resonance imaging of brain, which is a disease caused by chronic cerebral ischemic damage. We reviewed researches on the mechanism of the role of ischemic nonspecific inflammation in the white matter damage mediated by microglia activation, in order to provide reference and help for further mechanism studies.

Key words: Microglia; Inflammation; Vascular cognitive impairment; White matter lesion; Oligodendrocyte

李海龙，毕晓莹. 小胶质细胞激活介导非特异性炎症在血管性认知障碍白质脱髓鞘损伤机制中的研究进展[J]. 中国卒中杂志, 2015, 10(09): 771-777.

LI Hai-Long, BI Xiao-Ying. . Progress of Researches on the Mechanism of the Role of Nonspecific Inflammation Mediatedby Microglia Activation in the White Matter Demyelination of Vascular Cognitive Impairment[J]. Chinese Journal of Stroke, 2015, 10(09): 771-777.

参考文献

1 Iadecola C. The pathobiology of vascular dementia[J].
Neuron, 2013, 80:844-866.
2 Brickman AM, Siedlecki KL, Muraskin J, et al. White
matter hyperintensities and cognition:testing the
reserve hypothesis[J]. Neurobiol Aging, 2011, 32:1588-
1598.
3 Candelario-Jalil E, Thompson J, Taheri S, et al. Matrix
metalloproteinases are associated with increased
blood-brain barrier opening in vascular cognitive
impairment[J]. Stroke, 2011, 42:1345-1350.
4 Back SA, Kroenke CD, Sherman LS, et al. White
matter lesions defined by diffusion tensor imaging in
older adults[J]. Ann Neurol, 2011, 70:465-476.
5 Fernando MS, Simpson JE, Matthews F, et al.
White matter lesions in an unselected cohort of the
elderly:molecular pathology suggests origin from
chronic hypoperfusion injury[J]. Stroke, 2006,
37:1391-1398.
6 Simpson JE, Fernando MS, Clark L, et al. White
matter lesions in an unselected cohort of the
elderly:astrocytic, microglial and oligodendrocyte
precursor cell responses[J]. Neuropathol Appl
Neurobiol, 2007, 33:410-419.
7 Bai Z, Stamova B, Xu H, et al. Distinctive RNA
expression profiles in blood associated with
Alzheimer disease after accounting for white matter
hyperintensities[J]. Alzheimer Dis Assoc Disord,
2014, 28:226-233.
8 Rouhl RP, Damoiseaux JG, Lodder J, et al. Vascular
inflammation in cerebral small vessel disease[J].
Neurobiol Aging, 2012, 33:1800-1806.
9 Gallacher J, Bayer A, Lowe G, et al. Is sticky blood
bad for the brain?:Hemostatic and inflammatory
systems and dementia in the Caerphilly Prospective
Study[J]. Arterioscler Thromb Vasc Biol, 2010,
30:599-604.
10 Perry VH, Nicoll JA, Holmes C. Microglia in
neurodegenerative disease[J]. Nat Rev Neurol, 2010,
6:193-201.
11 Glass CK, Saijo K, Winner B, et al. Mechanisms
underlying inflammation in neurodegeneration[J].
Cell, 2010, 140:918-934.
12 Block ML, Zecca L, Hong JS. Microglia-
mediated neurotoxicity:uncovering the molecular
mechanisms[J]. Nat Rev Neurosci, 2007, 8:57-69.
13 Hanisch UK, Kettenmann H. Microglia:active
sensor and versatile effector cells in the normal and
pathologic brain[J]. Nat Neurosci, 2007, 10:1387-1394.
14 Biber K, Neumann H, Inoue K, et al. Neuronal
'On' and 'Off' signals control microglia[J]. Trends
Neurosci, 2007, 30:596-602.
15 Denes A, Ferenczi S, Halasz J, et al. Role of
CX3CR1(fractalkine receptor) in brain damage and
inflammation induced by focal cerebral ischemia in
mouse[J]. J Cereb Blood Flow Metab, 2008, 28:1707-
1721.
16 Cardona AE, Pioro EP, Sasse ME, et al. Control of
microglial neurotoxicity by the fractalkine receptor[J].
Nat Neurosci, 2006, 9:917-924.
17 Corona AW, Huang Y, O'Connor JC, et al. Fractalkine
receptor(CX3CR1) deficiency sensitizes mice to the
behavioral changes induced by lipopolysaccharide[J].
J Neuroinflammation, 2010, 7:93.
18 Tang Z, Gan Y, Liu Q, et al. CX3CR1 deficiency
suppresses activation and neurotoxicity of microglia/
macrophage in experimental ischemic stroke[J]. J
Neuroinflammation, 2014, 11:26.
19 Deng Y, Lu J, Sivakumar V, et al. Amoeboid
microglia in the periventricular white matter induce
oligodendrocyte damage through expression of
proinflammatory cytokines via MAP kinase signaling
pathway in hypoxic neonatal rats[J]. Brain Pathol,
2008, 18:387-400.
20 Boer K, Troost D, Jansen F, et al. Clinicopathological
and immunohistochemical findings in an autopsy case
of tuberous sclerosis complex[J]. Neuropathology,
2008, 28:577-590.
21 Liu Y, Zhao T, Yang Z, et al. CX3CR1 RNAi inhibits
hypoxia-induced microglia activation via p38MAPK/
PKC pathway[J]. Int J Exp Pathol, 2014, 95:153-157.
22 Wolf Y, Yona S, Kim KW, et al. Microglia, seen from
the CX3CR1 angle[J]. Front Cell Neurosci, 2013, 7:26.
23 Okun E, Griffioen KJ, Lathia JD, et al. Toll-like
receptors in neurodegeneration[J]. Brain Res Rev,
2009, 59:278-292.
24 Song M, Jin J, Lim JE, et al. TLR4 mutation reduces
microglial activation, increases Abeta deposits and
exacerbates cognitive deficits in a mouse model of
Alzheimer's disease[J]. J Neuroinflammation, 2011,
8:92.
25 Howell OW, Rundle JL, Garg A, et al. Activated
microglia mediate axoglial disruption that contributes
to axonal injury in multiple sclerosis[J]. J Neuropathol
Exp Neurol, 2010, 69:1017-1033.
26 Caso JR, Pradillo JM, Hurtado O, et al. Toll-
like receptor 4 is involved in subacute stress-
induced neuroinflammation and in the worsening of
experimental stroke[J]. Stroke, 2008, 39:1314-1320.
27 Caso JR, Pradillo JM, Hurtado O, et al. Toll-
like receptor 4 is involved in brain damage and
inflammation after experimental stroke[J]. Circulation,
2007, 115:1599-1608.
28 Ock J, Jeong J, Choi WS, et al. Regulation of Toll-like
receptor 4 expression and its signaling by hypoxia in
cultured microglia[J]. J Neurosci Res, 2007, 85:1989-
1995.
29 Bell MT, Puskas F, Agoston VA, et al. Toll-
like receptor 4-dependent microglial activation
mediates spinal cord ischemia-reperfusion injury[J].
Circulation, 2013, 128(11 Suppl 1):S152-156.
30 Wang Y, He H, Li D, et al. The role of the TLR4
signaling pathway in cognitive deficits following
surgery in aged rats[J]. Mol Med Rep, 2013, 7:1137-
1142.
31 Brea D, Blanco M, Ramos-Cabrer P, et al. Toll-like
receptors 2 and 4 in ischemic stroke:outcome and
therapeutic values[J]. J Cereb Blood Flow Metab,
2011, 31:1424-1431.
32 Qiu J, Xu J, Zheng Y, et al. High-mobility group box
1 promotes metalloproteinase-9 upregulation through
Toll-like receptor 4 after cerebral ischemia[J]. Stroke,
2010, 41:2077-2082.
33 Li H, Jin M, Lv T, et al. Mechanism of focal
cerebral ischemic tolerance in rats with ischemic
preconditioning involves MyD88- and TRIF-
dependent pathways[J]. Exp Ther Med, 2013, 6:1375-
1379.
34 Kuno R, Wang J, Kawanokuchi J, et al. Autocrine
activation of microglia by tumor necrosis factor-
alpha[J]. J Neuroimmunol, 2005, 162:89-96.
35 Olsson B, Hertze J, Lautner R, et al. Microglial
markers are elevated in the prodromal phase of
Alzheimer's disease and vascular dementia[J]. J
Alzheimers Dis, 2013, 33:45-53.
36 Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor
necrosis factor-alpha mediates oligodendrocyte death
and delayed retinal ganglion cell loss in a mouse
model of glaucoma[J]. J Neurosci, 2006, 26:12633-
12641.
37 Li J, Ramenaden ER, Peng J, et al. Tumor necrosis
factor alpha mediates lipopolysaccharide-induced
microglial toxicity to developing oligodendrocytes
when astrocytes are present[J]. J Neurosci, 2008,
28:5321-5330.
38 Koo JW, Russo SJ, Ferguson D, et al. Nuclear factor-
kappaB is a critical mediator of stress-impaired
neurogenesis and depressive behavior[J]. Proc Natl
Acad Sci USA, 2010, 107:2669-2674.
39 Miron VE, Boyd A, Zhao JW, et al. M2 microglia and
macrophages drive oligodendrocyte differentiation
during CNS remyelination[J]. Nat Neurosci, 2013,
16:1211-1218.
40 Segovia KN, McClure M, Moravec M, et al. Arrested
oligodendrocyte lineage maturation in chronic
perinatal white matter injury[J]. Ann Neurol, 2008,
63:520-530.
41 Miyamoto N, Maki T, Pham LD, et al. Oxidative
stress interferes with white matter renewal after
prolonged cerebral hypoperfusion in mice[J]. Stroke,
2013, 44:3516-3521.
42 Fischer R, Wajant H, Kontermann R, et al.
Astrocyte-specific activation of TNFR2 promotes
oligodendrocyte maturation by secretion of leukemia
inhibitory factor[J]. Glia, 2014, 62:272-283.
43 VonDran MW, Singh H, Honeywell JZ, et al. Levels of
BDNF impact oligodendrocyte lineage cells following
a cuprizone lesion[J]. J Neurosci, 2011, 31:14182-
14190.
44 Cui QL, Fragoso G, Miron VE, et al. Response of
human oligodendrocyte progenitors to growth factors
and axon signals[J]. J Neuropathol Exp Neurol, 2010,
69:930-944.
45 Wang Y, Cao M, Liu A, et al. Changes of inflammatory
cytokines and neurotrophins emphasized their roles
in hypoxic-ischemic brain damage[J]. Int J Neurosci,
2013, 123:191-195.
46 Pang Y, Zheng B, Fan LW, et al. IGF-1 protects
oligodendrocyte progenitors against TNFalpha-
induced damage by activation of PI3K/Akt and
interruption of the mitochondrial apoptotic pathway[J].
Glia, 2007, 55:1099-1107.
47 Lalancette-Hebert M, Gowing G, Simard A, et al.
Selective ablation of proliferating microglial cells
exacerbates ischemic injury in the brain[J]. J Neurosci,
2007, 27:2596-2605.
48 Mason JL, Suzuki K, Chaplin DD, et al. Interleukin-
1beta promotes repair of the CNS[J]. J Neurosci, 2001,
21:7046-7052.

[1]	梁潇, 钱海兵. 水通道蛋白4与卒中后认知障碍的关系研究进展[J]. 中国卒中杂志, 2022, 17(12): 1385-1390.
[2]	刘亚杰, 李玉娣, 黎凯锋, 陈哲锋, 凌莉. 基于高通量RNA-Seq技术探讨补阳还五汤治疗小鼠脑梗死的作用机制 [J]. 中国卒中杂志, 2022, 17(11): 1238-1246.
[3]	龚宇田, 黎洁洁. IL-6和动脉粥样硬化性缺血性卒中的关系研究进展[J]. 中国卒中杂志, 2022, 17(09): 1022-1026.
[4]	董雯, 姜鸣钰, 陈文涛, 刘文倩, 陈青芳, 赵顺英, 叶维贞, 温少红, 刘向荣. 阿司匹林和氯吡格雷联合应用对小鼠脑缺血损伤后骨髓及脑内炎症反应的影响[J]. 中国卒中杂志, 2022, 17(06): 605-610.
[5]	瓮佳旭, 仇鑫, 李子孝. TET2突变相关不确定潜能的克隆性造血与卒中发生发展的研究进展[J]. 中国卒中杂志, 2022, 17(04): 413-417.
[6]	刘文倩, 赵顺英, 叶维贞, 姜鸣钰, 陈文涛, 陈青芳, 温少红, 董雯, 刘向荣 . 毛柳苷在缺血性脑损伤中对白介素4诱导蛋白1表达和小胶质细胞激活及表型的影响[J]. 中国卒中杂志, 2022, 17(02): 134-141.
[7]	陈青芳, 赵顺英, 温少红, 董雯, 刘文倩, 龚婷, 陈文涛, 刘向荣, 王拥军. 长春西汀注射液在小鼠永久性脑缺血小胶质细胞表型转化中的作用研究[J]. 中国卒中杂志, 2021, 16(11): 1156-1163.
[8]	闫然, 上官艺, 仇鑫, 李子孝. DNA甲基化酶3A在动脉粥样硬化中的作用机制[J]. 中国卒中杂志, 2021, 16(11): 1178-1182.
[9]	吴章薇, 张通, 赵军, 张国军, 邵春青. 急性缺血性卒中后炎症因子水平与神经功能恢复的关系研究[J]. 中国卒中杂志, 2021, 16(10): 1023-1028.
[10]	王丹丹, 王晶, 王安心, 张怡君, 赵性泉. 超敏C反应蛋白与新发脑出血关系研究[J]. 中国卒中杂志, 2021, 16(07): 664-669.
[11]	廖艺斐，张慧，邹良玉. 神经炎症在动脉瘤性蛛网膜下腔出血后早期脑损伤中的作用[J]. 中国卒中杂志, 2021, 16(01): 92-96.
[12]	陆佩文，杨洁，邓秋琼，俞羚，曹雯炜，杜静，汪耀，周滟，徐群. 脑小血管病患者认知障碍早期功能网络连接性研究[J]. 中国卒中杂志, 2020, 15(12): 1268-1275.
[13]	刘明珠，孙冬，李华钢，李曾，梅斌，刘煜敏. 弗雷明汉卒中高风险增加新型冠状病毒病患者的炎症反应及不良预后[J]. 中国卒中杂志, 2020, 15(11): 1162-1167.
[14]	武翠梅，王改青，要振佳. 小鼠脑出血后不同时间点小胶质细胞极化状态的实验研究[J]. 中国卒中杂志, 2020, 15(10): 1094-1100.
[15]	中国卒中学会卒中后认知障碍研究圆桌会议专家组. 中国卒中后认知障碍防治研究专家共识[J]. 中国卒中杂志, 2020, 15(02): 158-166.